Annual Scientific Meeting - Acg - American College of

ACG’s 2014 Annual Scientific Meeting
Annual Scientific Meeting
Monday through Wednesday, October 20 through 22, 2014 • Terrace Ballroom
Join GI physicians from around the U.S. and the world for the ACG Annual Scientific Meeting. The meeting promises to deliver the latest
clinical information on timely topics in gastroenterology. As an ACG member, you can attend the three-day Annual Meeting for free – there
is no registration fee. Choose from 11 symposia, multiple networking events, and see the latest advances in technology and therapeutics
from exhibitors from around the globe. Additional breakfast sessions, 17 in total, will be offered for a nominal fee. Register today!
Be sure to visit poster presentations in the Exhibit Hall on Sunday, October 19th beginning at 3:30 pm, and enjoy the Exhibit Hall Opening
Reception beginning at 5:15 pm on Sunday.
Program Description
Returning this year is the Endoscopy Video Forum, “Live
from Philly! The 2nd Annual Endoscopy Video Forum.” The
Forum will feature the best video presentations submitted
from colleagues from across the U.S. and around the world.
Submitted during ACG’s Call for Abstracts and peer-reviewed
and selected for presentation, the cases will feature endoscopy
techniques, challenging or unique cases, and cases in the area
of GI endoscopy. During the session, the audience, along with
the Moderators, will vote to select the best video of ACG 2014.
The Annual Scientific Meeting program is designed primarily
for physicians in gastroenterology and hepatology, as well as
physician assistants, nurse practitioners and other advanced
practice healthcare professionals interested in the latest
information on state-of-the-art treatment of these illnesses.
Eleven scientific plenary symposia will allow attendees to
hear lecture presentations from experts and to participate
in interactive question and answer sessions with the faculty.
In addition, 17 optional scientific breakfast sessions will
be offered, where a smaller setting allows for heightened
interaction with the speakers and greater audience involvement.
Accreditation
The American College of Gastroenterology is accredited by
the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
Many sessions will use expert panel discussions in debate and
case-based formats.
ANNUAL
MEETING
The field of gastroenterology and hepatology continues to
see advancements in multiple areas relating to diagnostic
measures, therapeutic options and technology. In order to
provide appropriate and top-quality patient care, the clinician is
challenged to stay abreast of the changes and advancements
affecting the management of many gastrointestinal and liver
disease states. Throughout the three-day Annual Meeting, you
will be exposed to updates in a variety of topics, including
biologic therapy in IBD, hepatitis C, acute and chronic
pancreatitis, IBS, colonoscopy, the refractory esophageal
patient, case studies in IBD management, the inpatient
hepatology consult, the human microbiome, and more.
The American College of Gastroenterology designates this live
activity for a maximum of 16.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
Download ACG 2014 slides to your Apple
or Android smart device with eventScribe!
Follow along with the presenter when you download slides
using the eventScribe app by CadmiumCD. The eventScribe
app, native to Apple and Android devices including tablets,
phones, and Kindle Fire, can be downloaded in advance and
used onsite during the meeting. eventScribe lets you take
notes next to each slide, highlight information and draw on
each slide. Save your notes to reference after the meeting.
51
annual scientific
meeting slides
will be available on
course available on
Look for this symbol to see
if eventScribe slide downloads are available.
Annual Scientific Meeting Agenda – Monday, October 20
Monday, October 20, 2014
breakfast c: GI
Disease in Transitioning Teenagers:
Adults Aren’t Big Kids
6:30 am – 6:00 pm
6:00 am – 4:45 pm
MODERATOR: Sandeep K. Gupta, MD, FACG
Registration (Broad Street Atrium)
Cystic Fibrosis
Drucy S. Borowitz, MD
Discuss issues that carry over with patients as they transition
into adult practice, including nutrition and liver disease.
6:30 am – 7:45 am
OPTIONAL BREAKFAST SESSIONS
Cost is $60 per person/per session. Separate registration
required. A USB containing all ACG 2014 Breakfast Sessions
submissions will be provided to attendees registered for any
Breakfast Session. See ticket for room assignment. If you have
not registered, vist the ACG Registration Desk.
IBD
Judith R. Kelsen, MD
Outline how patients with childhood-onset IBD are different from
adult-onset disease.
breakfast a:
GIs in the Digital Age: The Power of
Social Media
EoE
Sandeep K. Gupta, MD, FACG
Describe issues faced by teenagers with GI disease including diet
compliance, medication use and independent access to health-care.
MODERATOR: Ryan Madanick, MD
To Socialize or Not to Socialize: The Pros and Cons of Social
Media Sites
Ryan Madanick, MD
Explain the threats to professionalism that involvement in social media
poses and how these threats can be minimized, and monitor and begin
to manage your own digital footprint.
breakfast d: A
GI Conditions
MODERATOR: Philip O. Katz, MD, FACG
GERD and Barrett’s
Philip O. Katz, MD, FACG
Formulate a cost-effective approach for the management of GERD and
Barrett’s esophagus.
Reputation Management: How to Use Your Online Brand to Bring
in New Patients
Kenneth Brown, MD
Explain how social media can improve patient care and how your online
brand can be used to bring in new patients.
Constipation
Amy E. Foxx-Orenstein, DO, FACG
Assess the need for diagnostic testing in patients with chronic
constipation.
Case Studies in Social Media: Dos and Don’ts
David T. Rubin, MD, FACG
Select a social media platform appropriate for personal and professional
needs.
breakfast b: Atypical
Cost-effective Approach to Common
Dyspepsia
Brian E. Lacy, MD, PhD, FACG
Identify a cost-effective approach for the treatment of dyspepsia.
Colitides
MODERATOR: Darrell S. Pardi, MD, MS, FACG
breakfast e:
Microscopic Colitis: What’s New in Diagnosis and Management
Darrell S. Pardi, MD, MS, FACG
Identify current and new methods to detect and treat microscopic
colitis.
MODERATOR: Felice Schnoll-Sussman, MD, FACG
Endoscopy 101: Esophageal and
Anorectal Motility, and Hands-on
Esophageal Manometry
Felice Schnoll-Sussman, MD, FACG
Interpret common esophageal motility problems, followed by a handson demonstration.
The Spectrum of Diverticular Disease: SCAD, SUDD
Brennan M. R. Spiegel, MD, MSHS, FACG
Utilize diagnostic tools to define the spectrum of diverticular diseases.
Anorectal Manometry
Satish S. C. Rao, MD, PhD, FACG
Interpret common anorectal motility problems, followed by a hands-on
demonstration.
Ischemic Colitis
Lawrence J. Brandt, MD, MACG
Summarize the pathophysiology and know the methods for diagnosing
and treating ischemic colitis.
Following the didactic lectures, attendees will participate in a
hands-on session taking place in the Hands-on Workshop Center in
the Exhibit Hall from 7:50 am-9:00 am.
52
6:00 am – 4:45 pm
REGISTRATION (Broad Street Atrium)
7:50 am – 6:00 pm
SCIENTIFIC MEETING
Annual Scientific Meeting Agenda – Monday, October 20
7:50 am – 8:00 am OPENING REMARKS
(Terrace Ballroom)
Harry E. Sarles, Jr., MD, FACG
ACG President
9:00 am – 9:30 am
PRESIDENT’S ADDRESS
(Terrace Ballroom)
Harry E. Sarles, Jr., MD, FACG
Introduced by:
Stephen B. Hanauer, MD, FACG
ACG President-Elect
8:00 am – 9:00 amPRESIDENT’S PLENARY SESSION 1
(Terrace Ballroom)
MODERATORS: Harry E. Sarles, Jr., MD, FACG
John R. Saltzman, MD, FACG
9:30 am – 10:30 am PRESIDENT’S PLENARY SESSION 2
(Terrace Ballroom)
1. Dronabinol Increases Pain Threshold in Non-Cardiac Chest
Pain: A Double Blind Placebo Controlled Trial
2014 ACG Auxiliary Award (Trainee)
Zubair Malik, MD, Levant Bayman, MSc, Jessica Valestine,
BSc, Ron Schey, MD, Temple University Hospital, Philadelphia,
PA, University of Iowa Hospitals and Clinics, Iowa City, IA
MODERATORS:
Stephen B. Hanauer, MD, FACG
John R. Saltzman, MD, FACG
6. Capnographic Monitoring Does Not Improve Detection
of Hypoxemia in Colonoscopy With Moderate Sedation. A
Randomized, Controlled Trial
2014 ACG Fellow Award
Paresh P. Mehta, MD, Gursimran Kochhar, MD, Mazen
Albeldawi, MD, Brian Kirsh, MD, Maged K. Rizk, MD, Brian
Putka, MD, Binu John, MD, Yinghong Wang, MD, Nicole
Breslaw, RN, John J. Vargo, MD, FACG, Cleveland Clinic,
Cleveland, OH
7. Young-Onset Colorectal Cancer: A More Aggressive Disease on the Rise
2014 ACG Colorectal Cancer Prevention Award
Xi E. Zheng, MD, PhD, Heather Yeo, MD, MHS, Doron
Betel, PhD, Manish A. Shah, MD, Weill Cornell Medical
College, New York, NY
3. Gender Differences in Research Productivity, Academic
Rank and Career Duration Among U.S. Academic Gastroenterology Faculty
2014 ACG/Naomi Nakao Gender-Based Research Award
Sarah J. Diamond, MD, Brintha K. Enestvedt, MD, MBA,
Charles Thomas, MD, Sima Desai, MD, Reshma Jagsi, MD,
Colleen Schmitt, MD, Oregon Health and Science University,
Portland, OR, University of Michigan, Ann Arbor, MI, Galen
Medical Group, Chattanooga, TN
ANNUAL
MEETING
2. Metal Versus Plastic for Pancreatic Pseudocyst Drainage:
Clinical Outcomes and Success
Reem Z. Sharaiha, MD, MSc, Ersilia M. DeFilippis, MD,
Prashant Keida, MD, Christine Boumitri, MD, Huei-Wen Lim,
MD, Eugene Han, MD, Harkarit Singh, MD, Saad S. Ghumman, MD, Monica Gaidhane, MD, Thomas Kowalski, MD, David Loren, MD, Michel Kahaleh, MD, FACG, Ali Siddiqui, MD,
Weill Cornell Medical Center, New York, NY, Thomas Jefferson
University, Philadelphia, PA
8. Impact of Retroflexion Versus Second Forward View Examination of the Right Colon on Adenoma Detection: A Multicenter Randomized Controlled Trial
2014 ACG Colorectal Cancer Prevention Award
Vladimir M. Kushnir, MD, Young Oh, MD, Thomas Hollander, BS, Chien-Huan Chen, MD, PhD, Gregory S. Sayuk,
MD, MPH, Nicholas Davidson, MD, FACG, Daniel Mullady,
MD, Faris M. Murad, MD, Noura M. Sharabash, MD, Eric
Ruettgers, MSN, RN, ANP-BC, Themistocles Dassopoulos, MD,
Jeffrey J. Easler, MD, C. Prakash Gyawali, MD, FACG, Steven
A. Edmundowicz, MD, Dayna S. Early, MD, FACG, Washington
University School of Medicine, St. Louis, MO, Medical College
of Wisconsin, Milwaukee, WI
4. SVR12 of 99% Achieved With a Ribavirin-Free Regiment
of ABT-450/r/Ombitasvir and Dasabuvir in HCV Genotype 1bInfected Patients
2014 ACG International Award
Andreas Maieron, MD, Massimo Puoti, MD, Jeffrey Enejosa,
MD, Ziv Ben-Ari, MD, Gunnar Norkrans, MD, Manuel RomeroGomez, MD, Wangang Xie, MD, PhD, Daniel Cohen, MD, Thomas Podsadecki, MD, Pietro Andreone, MD, Elisabeth Hospital,
Linz, Austria, A.O. Ospedale Niguarda Ca Granda, Milan, Italy,
AbbVie, Inc., North Chicago, IL, The Chaim Sheba Medical
Center, Tel Hashomer, Israel, Sahlgrenska University Hospital,
Göteborg, Sweden, Hospital Universitario Nuestra Senora De
Valme, Seville, Spain, University of Bologna, Bologna, Italy
9. Colonoscopy Is Associated With a Reduced Risk of Colon
Cancer and Mortality in Patients With Inflammatory Bowel
Diseases
2014 ACG Auxiliary Award (Member/Fellow)
Ashwin Ananthakrishnan, MD, MPH, Andrew Cagan, BS, Tianxi
Cai, PhD, Vivian Gainer, MS, Stanley Shaw, MD, PhD, Susanne
Churchill, PhD, Elizabeth Karlsin, MD, MPH, Shawn Murphy, MD, PhD, Isaac Kohane, MD, PhD, Katherine Liao, MD,
MPH, Massachusetts General Hospital, Boston, MA, Brigham
and Women’s Hospital, Boston, MA, Harvard School of Public
Health, Boston, MA, Partners Healthcare, Boston, MA
5. Normalization of Liver-Related Laboratory Parameters in
HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT-450/R/Ombitasvir, Dasabuvir and Ribavirin
Gregory Everson, MD, Samuel Lee, MD, Stefan Zeuzem, MD,
Pietro Andreone, MD, Stanislas Pol, MD, Marc Bourlière, MD,
Angeles Castro, MD, PhD, Marina Berenguer, MD, Sandra
Lovell, PhD, Marcos Pedrosa, MD, PhD, Roger Trinh, MD,
MPH, University of Colorado Denver and Hospital, Aurora, CO,
University of Calgary, Calgary, Alberta, Canada, J.W. Goethe
University, Frankfurt, Germany, University of Bologna, Bologna, Italy, Université Paris Descartes et Hôpital, Paris, France,
Hopital Saint Joseph, Marseille, France, Complejo Hospitalario
Universitario A Coruña, A Coruña, Spain, Hospital Universitario La Fe, Valencia, Spain, AbbVie, Inc., North Chicago, IL
10. The Effect of Immunosuppressive Therapy on
Cardiovascular Disease in Patients With Inflammatory Bowel
Disease
Sudeep D. Thapa, MD, Hiba Hadid, MD, Syed-Mohammed
Jafri, MD, Mohammed Imam, DO, Jason Schairer, MD,
Internal Medicine, Henry Ford Hospital, Detroit, MI
53
Annual Scientific Meeting Agenda – Monday, October 20
10:00 am – 4:30 pm
EXHIBIT HALL OPENS
(Exhibit Halls DE)
12:45 pm – 1:30 pm EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
10:00 am – 4:30 pm
HANDS-ON WORKSHOP CENTER
(Exhibit Halls DE, Booth #104)
12:45 pm – 2:15 pm LUNCH BREAK – VISIT EXHIBITS
(Exhibit Halls DE)
10:30 am – 11:30 am BREAK – VISIT EXHIBITS
(Exhibit Halls DE)
12:45 pm – 2:15 pm POSTER SESSION
(Exhibit Halls DE)
10:30 am – 11:30 am EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
12:45 pm – 2:15 pm ACG-FDA PUBLIC FORUM (Room 122AB)
11:30 am – 12:45 pm SIMULTANEOUS SYMPOSIA 1
Toward Improving the Quality of Colonoscopy:
Evidence-Based State of the Art in Bowel Preparation
simultaneous symposia 1a:Choosing
MODERATORS: Lawrence Cohen, MD, FACG and Robert Fiorentino, MD
and Monitoring
Biologic Therapy for IBD
Topics to be discussed during this special workshop include:
MODERATOR: David T. Rubin, MD, FACG
The FDA Perspective on Bowel Preparation Registration Trials
Robert Fiorentino, MD
Positioning Biologics in Ulcerative Colitis
Bruce E. Sands, MD, MS, FACG
Describe how timing and selection factor into the implementation of
biologic therapy for UC.
What Is the Evidence for an Optimal Dosing Scheme and
Bowel Preparation Formulation? In Clinical Practice? As the
Comparator Arm for Clinical Studies?
Paul Moayyedi, MB, ChB, PhD, FACG
Positioning Biologics in Crohn’s Disease
David T. Rubin, MD, FACG
Describe how timing and selection factor into the implementation of
biologic therapy for Crohn’s disease.
What Are the Immediate and Delayed Safety Issues Surrounding Over-the-Counter and Prescription Bowel Preparations?
Philip S. Schoenfeld, MD, FACG
Appropriate Use and Interpretation of Drug Levels
Marla C. Dubinsky, MD
Incorporate a rational approach to therapeutic drug monitoring in IBD.
simultaneous symposia 1b: Hepatitis
What Are the Optimal Endpoints for Assessing Bowel
Preparation in Clinical Practice or Trials?
Douglas K. Rex, MD, MACG
C: The Future Has
Q & A
Arrived
MODERATOR: Stanley M. Cohen, MD
Evaluating Your Patient for Therapy Using All Oral Therapies
Stanley M. Cohen, MD
Use elastography to identify patients with hepatitis C (including fibrosis
assessment).
1:45 pm – 2:15 pm EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
2:15 pm – 3:00 pm SIMULTANEOUS PLENARY SESSIONS
Plenary Session 1: Functional Bowel Disorder/Pediatrics
Genotype 1 Treatment Options
Mitchell L. Shiffman, MD, FACG
Apply recent phase 3 treatment options for genotype 1 infected
individuals who are treatment naïve and non-responders to previous
therapy.
MODERATORS: Brian E. Lacy, MD, PhD, FACG
Samra Sarigol-Blanchard, MD
11. Linaclotide Efficacy on Dyspepsia Symptoms Using
Nepean Dyspepsia Index (NDI) in a Phase 3B Trial of CIC
Patients With Bloating
Anthony Lembo, MD, Nicholas J. Talley, MD, PhD, FACG,
Steven J. Shiff, MD, Bernard J. Lavins, MD, Robyn T. Carson,
MPH, Rick Blakesley, PhD, Xinming Hao, PhD, Mark G. Currie, PhD, Caroline Kurtz, PhD, Jeffrey M. Johnston, MD, University of Newcastle, Callaghan, New South Wales, Australia,
Forest Laboratories, Jersey City, NJ, Ironwood Pharmaceuticals, Cambridge, MA
Genotype 2/3 Other Populations
Andrew J. Muir, MD, MHS
Apply treatment options for genotype 2/3 infected individuals including
non-responding genotype 3 cirrhotic patients, implement treatment
strategies in special populations including those who are (a) HCV/HIV
infected and (b) awaiting liver transplant, and explain post-transplant
outcomes.
12. Analysis of Exhaled Volatile Organic Compounds Reveals
New Biomarkers for Irritable Bowel Syndrome
2014 ACG Fellow Award
Sophia A. Patel, MD, Nishaben Patel, MD, Vera Okwu,
MD, Ammar Matloob, MD, David Grove, PhD, Ellen Rome,
MD, Raed Dweik, MD, Naim Alkhouri, MD, Pediatric GI,
Cleveland Clinic Children’s, Cleveland, OH; Cleveland Clinic
Respiratory Institute, Cleveland, OH; Cleveland Clinic Pediatric
Department, Cleveland, OH
54
Annual Scientific Meeting Agenda – Monday, October 20
13. Urgency as a Measure of Treatment Effect Due to
Eluxadoline
Anthony Lembo, MD, David Andrae, MD, Scott Dove, MD,
Paul Covington, MD, Beth Israel Deaconess Medical Center,
Boston, MA, Furiex Pharmaceuticals, Morrisville, NC
18. Post-Operative Mortality for the Inflammatory Bowel
Diseases: A Systematic Review and Meta-Analysis of
Population-Based Studies
2014 ACG Fellow Award
Sundeep Singh, MD, Ahmed Al-Darmaki, MD, Alexandra
Frolkis, PhD, Cynthia H. Seow, MD, Yvette P. Leung, MD,
Kerri L. Novak, MD, Subrata Ghosh, MD, Remo Panaccione,
MD, Gilaad G. Kaplan, MD, Division of Gastroenterology,
University of Calgary, Calgary, Alberta, Canada, Department of
Medicine, University of Calgary, Calgary, Alberta, Canada
14. Plecanatide, a Novel Uroguanylin Analog: A 12-week,
Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging
Trial to Evaluate Efficacy and Safety in Patients With Irritable
Bowel Syndrome With Constipation (IBS-C)
Philip B. Miner, MD, FACG, Robert DeLuca, MD, Marianela
D. La Portilla, MD, Eveline Padila, MD, William Koltun, MD,
Othon H. Wiltz, MD, Kunwar Shailubhai, PhD, MBA, Gary S.
Jacob, PhD, Patrick Griffin, MD, Laura M. Barrow, PharmD,
R&D, Synergy Pharmaceuticals, Inc., Doylestown, PA, Genoma
Research Group, Miami, FL, Columbus Clinical Services,
Miami, FL, Medical Center for Clinical Research, San Diego,
CA, Oklahoma Center for Clinical Research, Oklahoma City,
OK, Medical Research Unlimited, Hialeah, FL, South Medical
Research Center, Miami, FL
3:00 pm – 3:45 pm SPECIAL LECTURE (Terrace Ballroom 3)
The American Journal of Gastroenterology Lecture –
Treatment of IBD: Where We Are and Where We Are Going
Charles N. Bernstein, MD, FACG
Evaluate the latest treatment options for patients with IBD.
(See page 15 for more information.)
Plenary Session 2: IBD
MODERATORS: Uma Mahadevan, MD, FACG
Sunanda V. Kane, MD, MSPH, FACG
EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
3:45 pm – 4:40 pm BREAK – VISIT EXHIBITS
(Exhibit Halls DE)
3:55 pm – 4:35 pm SPECIAL PROGRAM (Room 122AB)
ABIM’s Maintenance of Certification Program
Attend this informational session to understand how the changes
to ABIM’s MOC Program requirements affect you.
4:45 pm – 6:00 pm 16. Safety of Vedolizumab Alone or With Concomitant
Corticosteroids and/or Immunosuppressants in Patients With
Ulcerative Colitis or Crohn’s Disease
Edward V. Loftus, MD, FACG, Jean-Frederic Colombel, MD,
PhD, Corey A. Siegel, MD, James D. Lewis, MD, FACG, Brihad
Abhyankar, MBA, Serap Sankoh, PhD, Michael Smyth, MBA,
Catherine Milch, MD, Mayo Clinic, Rochester, MN, Icahn
School of Medicine at Mount Sinai, New York, NY, DartmouthHitchcock Medical Center, Lebanon, NH, Perelman School of
Medicine at the University of Pennsylvania, Philadelphia, PA,
Takeda Global Research and Development Centre (Europe)
Ltd., London, U.K., Takeda Pharmaceuticals International Co.,
Cambridge, MA
17. Does End-to-End Versus Side-to-Side Anastomosis in
Postoperative Crohn’s Disease Matter? Prospective 2-Year
Evaluation of Postoperative Quality of Life, Health Care
Utilization, and Clinical Activity
Mahesh Gajendran, MD, Claudia Ramos Rivers, MD, Jana G.
Hashash, MD, Miguel D. Regueiro, MD, FACG, Andrew Watson,
MD, Anthony J. Bauer, PhD, Leonard Baidoo, MD, Arthur M.
Barrie, MD, Marc Schwartz, MD, Jason Swoger, MD, MPH,
Michael A. Dunn, MD, David G. Binion, MD, Department of
Medicine, University of Pittsburgh, Pittsburgh, PA, Division
of Gastroenterology, Hepatology and Nutrition, University of
Pittsburgh, Pittsburgh, PA, Division of Colorectal Surgery,
University of Pittsburgh, Pittsburgh, PA
55
SIMULTANEOUS SYMPOSIA 2
ANNUAL
MEETING
15. Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis
Neeraj Narula, MD, John K. Marshall, MD, Jean-Frederic
Colombel, MD, PhD, Grigorios I. Leontiadis, MD, Zack
Muqtadir, MD, Walter Reinisch, MD, PhD, Mount Sinai
Hospital, New York, NY, McMaster University, Hamilton,
Ontario, Canada
3:30 pm – 4:30 pm Annual Scientific Meeting Agenda – Monday, October 20
4:45 pm – 6:00 pm SIMULTANEOUS SYMPOSIA 2
simultaneous symposia 2a:Clearing
V2. Endoscopic Management of High-Grade Dysplastic
Barrett’s With Esophageal Varices
William Palmer, MD, Milena Di Leo, MD, Manol Jovani, MD,
Herbert Wolfsen, MD, FACG, Murli Krishna, MD, Michael
Wallace, MD, MPH, FACG, Mayo Clinic, Jacksonville, FL,
Vita-Salute San Raffaele University, Scientific Institute San
Raffaele, Milan, Italy, Humanitas Research Hospital, Milan,
Rozzano, Italy
Up Confusion in Day-to-day Pancreatic Issues
MODERATOR: Santhi Swaroop Vege, MD, FACG
Changing Outcomes in Acute Pancreatitis
Santhi Swaroop Vege, MD, FACG
Identify the management options in acute pancreatitis which improve
patient outcomes.
V3. Endoscopic Full Thickness Resection (EFTR) of a
Subepithelial Tumor With Extensive Muscularis Propria (MP)
Involvement
Stavros Stavropoulos, MD, Rani Modayil, MD, John Allendorf,
MD, Collin Brathwaite, MD, James Grendell, MD, Winthrop
University Hospital, Mineola, New York, NY
Painful Chronic Pancreatitis: Scope or Knife
Timothy B. Gardner, MD, MS, FACG
Differentiate between the endoscopic or surgical management of chronic
pancreatitis.
V4. Percutaneous Endoscopic Debridement and Washout of a
Bilateral, Loculated, Hepatic Abscess: A Minimally Invasive
Approach to a High-Risk Surgical Situation
Ryan Gaffney, DO, Niraj Gusani, MD, MS, Neil Bhayani,
MD, MHS, Karen Krok, MD, Ian Schreibman, MD, Abraham
Mathew, MD, MHES, Matthew Moyer, MD, MS, Penn State
Milton S. Hershey Medical Center and College of Medicine,
Hershey, PA
Evaluation and Management of Pancreatic Cysts
William R. Brugge, MD, FACG
Determine the most appropriate treatment and management strategies
for pancreatic cysts.
simultaneous symposia 2b:Deciphering
IBS:
Understanding the Diverse Pathophysiology
V5. Successful Endoscopic Resection of Stage T1 Intraductal
Biliary Adenocarcinoma
Truptesh Kothari, MD, MS, Christine Granato, MD, Shivangi
Kothari, MD, Glen Hintz, MS, Jennifer Lewis, MD, Asad Ullah,
MD, Ashok Shah, MD, Vivek Kaul, MD, FACG, University of
Rochester Medical Center, Rochester, NY, G. Hintz, Rochester
Institute of Technology, Rochester, NY
MODERATOR: William D. Chey, MD, FACG
Food Allergies and Food Sensitivities in IBS
Sheila E. Crowe, MD, FACG
Counsel IBS patients on how foods contribute to the generation of IBS
symptoms.
An Evidence-based Approach to Dietary Treatment of IBS
Brian E. Lacy, MD, PhD, FACG
Perform an evidence-based review of different diets used to treat IBS.
V6. Endoscopic Therapy Using Self-Expandable Metal Stents
for Walled-Off Pancreatic Necrosis
Susana Lopes, MD, Filipe Vilas-Boas, MD, Pedro Pereira, MD,
Armando Ribeiro, MD, Guilherme Macedo, MD, PhD, Centro
Hospitalar S. João, Porto, Portugal
IBS as an Inflammatory Condition
William D. Chey, MD, FACG
Identify new physiologic processes involved in the development of IBS
and discuss potential treatments.
V7. Endoscopic Mucosal Resection of a Diverticular Polyp
Raul Badillo, MD, Michael Wallace, MD, MPH, FACG, Mayo
Clinic, Jacksonville, FL
simultaneous symposia 2c:Live
from Philly! The 2nd Annual Endoscopy Video Forum
V8. Endoscopic Retrograde Appendicitis Therapy (ERAT): A New Endoscopic Technique From China
Jitao Song, MD, Bing-Rong Liu, MD, PhD, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
MODERATORS: Seth A. Gross, MD, FACG, David A. Greenwald, MD, FACG,
and Daniel J. Pambianco, MD, FACG
This Video Forum Symposium will feature the best video
presentations submitted by colleagues from across the U.S. and
around the world. Submitted during ACG’s Call for Abstracts
and peer-reviewed and selected for presentation, the cases will
feature endoscopy techniques, challenging or unique cases,
and cases in the area of GI endoscopy. During the session,
the audience, along with the Moderators, will vote to select the
best video of ACG 2014. Attendees will view videos showcasing
interesting endoscopic findings and techniques encountered in
daily clinical practice.
6:00 pm – 6:30 pm V1. Incarcerated, Retroflexed Endoscope Associated With a
Para-Esophageal Hernia
Yazen Qumsiyeh, BS, Bashar Qumseya, MD, MPH, Michael
Wallace, MD, MPH, FACG, Herbert Wolfsen, MD, FACG, Mayo
Clinic Florida, Jacksonville, FL
56
ANNUAL BUSINESS MEETING (Terrace Ballroom 3)
College Members and Fellows invited.
Annual Scientific Meeting Agenda – Tuesday, October 21
breakfast h: Common
(Yet Controversial) Topics in
Pancreaticobiliary Disease
Tuesday, October 21, 2014
6:45 am – 6:15 pm
6:00 am – 5:00 pm
MODERATOR: Douglas G. Adler, MD, FACG
REGISTRATION (Broad Street Atrium)
SOD: Does it Exist?
Martin L. Freeman, MD, FACG
Explain the latest evidence characterizing sphincter of Oddi dysfunction.
6:45 am – 8:15 am
OPTIONAL BREAKFAST SESSIONS
Cost is $60 per person/per session. Separate registration
required. A USB containing all ACG 2014 Breakfast Sessions
submissions will be provided to attendees registered for any
Breakfast Session. See ticket for room assignment. If you have
not registered, vist the ACG Registration Desk.
Gallbladder Polyps: What to Do?
Jason D. Conway, MD, MPH
Judge when to resect, when to follow and when to ignore.
Large Stones Made Easy
Douglas G. Adler, MD, FACG
Discuss the techniques to be used alone and in combination to remove
large stones.
breakfast f:
Doctor, Do I Have to Take this Medicine
Forever? Escalation and De-escalation of Therapy in
IBD
breakfast i:
Functional Anorectal Disease: Do Ask and
MODERATOR: Miguel D. Regueiro, MD, FACG
Do Tell
Can You Stop Therapy in the Patient in Deep Remission?
Asher Kornbluth, MD
Adjust therapy for patients’ deep remission.
MODERATOR: Amy E. Foxx-Orenstein, DO, FACG
Approach to the Patient Not in Deep Remission: Treat to Target
Jean-Paul Achkar, MD, FACG
Describe the concept of treat-to-target and its current application to
practice.
Medical, Endoscopic and Surgical Treatments for Incontinence
Michael D. Brown, MD, FACG
Discuss evidence-based therapies for the treatment of fecal
incontinence.
Continuing Therapy in the Patient With Infection or Malignancy
Miguel D. Regueiro, MD, FACG
Justify the use of biologics during a treatment complication and identify
when to stop immunosuppression.
breakfast g: Using
Practice
Pelvic Floor Dysfunction: How to Diagnose and How to Treat
Amy E. Foxx-Orenstein, DO, FACG
Identify the patient with pelvic floor dysfunction and construct an
individualized treatment program.
New ACG Guidelines in Clinical
MODERATOR: John E. Pandolfino, MD, MSCI, FACG
breakfast j:
Esophageal Eosinophilia and EoE: Are They Different?
Evan S. Dellon, MD
Describe the new ACG clinical guidelines for EoE and esophageal
eosinophilia.
MODERATOR: Richard I. Rothstein, MD, FACG
Pushing the Envelope With New
Endoscopic Techniques
Perforation: We Can Fix That!
Louis-Michel Wong Kee Song, MD
Discuss the latest techniques and devices for closing luminal perforations.
GERD: PPIs and Is There a Dark Side?
Marcelo F. Vela, MD, MSCR, FACG
Explain the new ACG clinical guidelines for GERD.
Want to Lose Weight? The Endoscopic Options
Richard I. Rothstein, MD, FACG
Describe endoscopic management of obesity.
Achalasia: Diagnosis and Optimization of Treatment
John E. Pandolfino, MD, MSCI, FACG
Discuss the new ACG clinical guidelines for achalasia.
Endoscopic Treatment of Hemorrhoids
Waqar A. Qureshi, MD, FACG
Identify new endoscopic therapies for hemorrhoid treatment.
57
ANNUAL
MEETING
Urgency, Tenesmus and Leakage: How Can I Help?
Satish S. C. Rao, MD, PhD, FACG
Explain the physiology of the pelvic floor and identify risk factors for
tenesmus, urgency and fecal soiling.
Annual Scientific Meeting Agenda – Tuesday, October 21
breakfast k: The
Gastroenterologist and the Pregnant Patient
6:00 am – 5:00 pm
REGISTRATION (Broad Street Atrium)
8:30 am – 6:15 pm
SCIENTIFIC MEETING
MODERATOR: Sunanda V. Kane, MD, MSPH, FACG
8:30 am – 10:00 am SIMULTANEOUS PLENARY SESSIONS
GI Meds in Pregnancy
Sunanda V. Kane, MD, MSPH, FACG
Identify available pharmacological therapies that are safe for treatment of
GI disorders in the pregnant patient.
Plenary Session 1: Endoscopy / Colorectal Cancer Prevention
MODERATORS: Mark B. Pochapin, MD, FACG
David A. Johnson, MD, MACG
IBD and Pregnancy
Sonia Friedman, MD, FACG
Define strategies for a successful pregnancy outcome in the IBD patient,
including fertility, preparation of the patient for pregnancy, monitoring
and postpartum issues.
19. A Phase IIb Study Comparing the Safety and Efficacy of
Remimazolam and Midazolam in Colonoscopy Patients
Daniel J. Pambianco, MD, FACG, Keith Borkett, BSc, Dennis
Riff, MD, Peter Winkle, MD, Howard Schwartz, MD, Timothy
Melson, MD, Karin Wilhelm-Ogunbiyi, MD, Charlottesville Medical Research, Charlottesville, VA, Paion UK Ltd., Cambridge,
United Kingdom, Anaheim Clinical Trials, Anaheim, CA, Miami
Research Institute, Miami, FL, Helen Keller Hospital, Sheffield, AL, PAION Deutschland GmbH, Anchen, Germany
Liver Disease in Pregnancy
Tram T. Tran, MD
Evaluate diagnostic and management options for liver diseases in
pregnancy.
breakfast l:
20. What Is the Optimum Time to Do Endoscopy in Acute
Caustic Ingestion?
Munish Ashat, MD, Pradeep K. Siddappa, DM, Saroj K. Sinha,
DM, Usha Dutta, DM, Rakesh Kochhar, DM, Gastroenterology,
Post Graduate Institute of Medical Education and Research,
Panchkula, Haryana, India
Fatty Liver Diseases: You Can’t Escape
Them
MODERATOR: Mary E. Rinella, MD, FACG
Non-Alcoholic Fatty Liver Disease: What Is Beyond Vitamin E?
Mary E. Rinella, MD, FACG
Evaluate patients with non-alcoholic fatty liver disease and
identify which patients require a liver biopsy and which can be
followed. Discuss current therapies available and those in the
pipeline.
21. Volumetric Laser Endomicroscopy in Barrett’s Esophagus – Feasibility of Use and Detection of Dysplasia in
Clinical Practice
Jeffrey Mosko, MD, FRCPC, Sumeet K. Tewani, MD, Ivana
Dzeletovic, MD, Gyanprakash Ketwaroo, MD, Tyler Berzin, MD,
Ram Chuttani, MD, Mandeep Sawhney, MD, Douglas Pleskow,
MD, Beth Israel Deaconess Medical Center and Harvard
Medical School, Boston, MA
One Bourbon, One Scotch and One Beer: What to Do When They
Are Drinking
Vijay H. Shah, MD, FACG
Classify clinical spectrum of alcoholic fatty liver disease, who requires
therapy and with what, and how to apply the Lille criteria in treatment of
alcoholic hepatitis.
22. Natural Orifice Endoscopic Surgery (NOTES) Techniques
for Full Thickness R0 Endoscopic Resection of Deep Seated
Subepithelial Tumors (SETs): First U.S. Cases
Stavros Stavropoulos, MD, Rani J. Modayil, MD, Collin Brathwaite, MD, Kumkum S. Patel, MD, Thomas Coppola, DO,
John Allendorf, MD, David Friedel, MD, James Grendell, MD,
Winthrop University Hospital, Mineola, NY
Recognizing and Preventing Drug-induced Liver Injury in Those With
Chronic Liver Disease, Including Those With Fatty Liver
Victor J. Navarro, MD
Identify the different types of drug-induced liver disease, explain how
those with non-alcoholic fatty liver disease, in general, are not at higher
risk of drug-induced liver injury, determine how much acetaminophen can
be administered and which populations require caution, and plan how
to approach patients with chronic liver disease who require potentially
hepatotoxic medicines.
breakfast m: Medicolegal
23. Over-The-Scope-Clip and Cap-Assisted Method for the Resection of Submucosal Lesions of the Gastrointestinal Tract:
A Multi-Center Study
Shabnam Sarker, MD, Marcel Sandmann, MD, Martin
Faendrich, MD, Kondal Kyanam Kabir Baig, MD, Klaus
Monkemuller, MD, PhD, Gastroenterology, University of
Alabama, Birmingham, AL, Klinikum Dortmund, Dortmund,
Germany
Issues in Gastroenterology
MODERATOR: Richard S. Bloomfeld, MD, FACG
Why Are Gastroenterologists Sued?
Richard S. Bloomfeld, MD, FACG
Identify top reasons gastroenterologists are named in lawsuits.
24. Is Cold Biopsy the Best Method for Diminutive Colonic
Polyp Removal? A Systematic Review and Meta-analysis
Dany Raad, MD, Priyam Tripathi, MD, MPH, Gregory Cooper,
MD, FACG, Yngve Falck-Ytter, MD, Case Western Reserve University/University Hospitals Case Medical Center/VA Medical
Center, Cleveland, OH
Documentation and Communication Tips to Prevent Lawsuits
John Baillie, MB, ChB, FACG
Describe ways to improve documentation and communication to modify
your risk of adverse medicolegal events.
Refusing and Dismissing Problem Patients
Andrew D. Feld, MD, JD, FACG
Establish policies for handling challenging patients in your practice.
58
Annual Scientific Meeting Agenda – Tuesday, October 21
25. Withdrawal Times, Adenoma Detection Rates, and Risk of
Interval Colorectal Cancer
2014 ACG Colorectal Cancer Prevention Award
Aasma Shaukat, MD, MPH, FACG, Thomas Rector, PhD, Timothy R. Church, PhD, Frank Lederle, MD, Adam S. Kim, MD,
Jeffrey Rank, MD, John I. Allen, MD, Minneapolis VA Medical
Center, Minneapolis, MN, University of Minnesota, Minneapolis, MN, Minnesota Gastroenterology, PA, Minneapolis, MN
31. Idiosyncratic Drug-Induced Liver Injury (DILI) in the United States: A Report of 1,257 Prospectively Enrolled Patients
2014 ACG Governors Award for Excellence in Clinical Research
Naga P. Chalasani, MD, FACG, Herbert Bonkovsky, MD, FACG,
Robert Fontana, MD, William Lee, MD, FACG, Andrew Stolz,
MD, Jay Talwalkar, MD, FACG, Rajender Reddy, MD, FACG,
Paul Watkins, MD, Victor Navarro, MD, Huiman Barnhart,
PhD, Jiezhun Gu, PhD, Jose Serrano, MD, Indiana University
School of Medicine, Indianapolis, IN, Carolinas Health Care
System, Charlotte, NC, University of Michigan, Ann Arbor, MI,
UT-Southwestern, Dallas, TX, University of Southern California, Los Angeles, CA, Mayo Clinic, Rochester, MN, University
of Pennsylvania, Philadelphia, PA, University of North Carolina, Chapel Hill, NC, Einstein Medical Center, Philadelphia,
PA, Duke Clinical Research Institute, Durham, NC, NIDDK,
Bethesda, MD
26. A Phase-3 Placebo-Controlled Trial of Celecoxib in Pediatric Subjects With Familial Adenomatous Polyposis
Carol A. Burke, MD, FACG, Patrick M. Lynch, MD, Robin K.
Phillips, MD, Manuela F. Berger, MD, Chunming Li, PhD, Dinu
Iorga, MD, Cleveland Clinic, Cleveland, OH, MD Anderson
Cancer Center, Houston, TX, St. Marks Hospital, Middlesex,
London, United Kingdom, Pfizer, Inc., New York, NY
32. Health Related Quality of Life (HRQL) and Health Utilities (HU) of Patients With Chronic Hepatitis C (CH-C) Treated
With an Interferon (IFN)-Free Regimen Containing Ledipasvir
(LDV) and Sofosbuvir (SOF)
Zobair Younossi, MD, MPH, FACG, Maria Stepanova, PhD,
Patrick Marcellin, MD, PhD, Nezam Afdhal, MD, Kris V.
Kowdley, MD, FACG, Stefan Zeuzem, MD, Linda Henry,
PhD, Sharon Hunt, MBA, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA;
CLDQ LLC, Washington, DC, Viral Hepatitis Research Unit
in Hospital Beaujon, Clichy, France, Beth Israel Deaconess
Medical Center, Boston, MA, Digestive Diseases Institute,
Digestive Diseases Institute, Virginia Mason Clinic, Seattle,
WA, Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany, Betty and Guy Beatty Center for
Integrated Research, Inova Health System, Falls Church, VA
Plenary Session 2: Liver
MODERATORS: Kris V. Kowdley, MD, FACG
Paul Y. Kwo, MD, FACG
ANNUAL
MEETING
27. Statewide, Population-Based Lynch Syndrome Screening by Microsatellite Instability Testing in Colorectal Cancer
Patients ≤ Age 50: Prevalence, Determinants of Testing and
Timing of Result Availability in Relation to Surgery
2014 ACG Governors Award for Excellence in Clinical Research
Jordan J. Karlitz, MD, Mei-chin Hsieh, MSPH, Yong Liu, BS,
Christine Blanton, MD, Beth Schmidt, MSPH, Meredith Sherrill, MD, Sanjay Sikka, MD, Giuseppe Gagliardi, MD, XiaoCheng Wu, MD, MPH, Vivien W. Chen, PhD, MPH, Medicine,
Tulane University School of Medicine, New Orleans, LA;
Louisiana Tumor Registry, School of Public Health, Louisiana
State University Health Sciences Center, New Orleans, LA
33. Management of Hemoglobin Decrease in Patients
Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With
or Without Ribavirin in HCV Genotype 1-infected Patients
Vinod Rustgi, MD, FACG, David Bernstein, MD, FACG, Thomas
Sepe, MD, FACG, William King, MD, Moises Diago, MD,
Pietro Andreone, MD, Daniel Forton, PhD, Hendrik Reesink,
MD, Peter Ferenci, MD, Yiran Hu, MS, Jeffrey Enejosa, MD,
Daniel Cohen, MD, Yan Luo, MD, PhD, Marcos Pedrosa, MD,
PhD, John Vierling, MD, Metropolitan Research, Fairfax, VA,
North Shore University Hospital (BRANY), Manhasset, NY,
University Gastroenterology, Providence, RI, Trial Management
Associates, LLC, Wilmington, NC, Hospital Quirón de Valencia,
Unidad de Hepatología, Servicio de Aparato Digestivo, Valencia, Spain, Department of Medical and Surgical Sciences,
University of Bologna, Bologna, Italy, St. George’s, University
of London, London, United Kingdom, Academisch Medisch
Centrum, Universiteit van Amsterdam, Gastroenterology &
Hepatology, Amsterdam, Netherlands, Department of Internal
Medicine 3, Medical University of Vienna, Vienna, Austria,
AbbVie Inc., North Chicago, IL, Advanced Liver Therapies,
Baylor St. Luke’s Medical Center, Houston, TX
28. Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From
the Third National Health and Nutrition Examination Survey
Huafeng Shen, MD, Ghulamullah Shahzad, MD, Mahreema
Jawairia, MD, Paul Mustacchia, MD, NUMC, East Meadow, NY
29. Serum Ceruloplasmin, Ferritin, and Their Ratio Are
Significantly Associated with Nonalcoholic Steatohepatitis in
Patients with NAFLD
Danny Issa, MD, Rocio Lopez, MS, Ariel E. Feldstein, MD,
Mohamed Yaseen Alsabbagh, MD, Naim Alkhouri, MD,
Cleveland Clinic, Cleveland, OH
30. Mean Platelet Volume, Red Cell Distribution Width to
Platelet Count Index, Globulin Platelet Index and 12 Other
Simple Non-invasive Fibrosis Scores: How Much Do Routine
Blood Tests Tell About Liver Fibrosis?
2014 ACG Governors Award for Excellence in Clinical Research
Ragesh B. Thandassery, MD, DM, Anil John, MD, DM, MRCP,
Madiha Soofi, MD, Syed A. Mohiuddin, MBBS, Mohammed E.
Elbadri, MD, Saad Al Kaabi, MD, Division of Gastroenterology,
Department of Medicine, Hamad Medical Corporation, Doha,
Qatar, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar
34. Sex, Age and Race Are Associated With Increased Risk of
Exposure to Hepatitis E in the U.S.
Tyler B. Fleming, MD, Alla Y. Grigorian, MD, PhD, Bilal
Aslam, MS, IV, Philip Westgate, PhD, Houssam E. Mardini,
MD, MPH, University of Kentucky College of Medicine, Lexington, KY, University of Kentucky College of Public Health,
Lexington, KY
59
Annual Scientific Meeting Agenda – Tuesday, October 21
simultaneous symposia 3b:Reading
35. The Impact of Hyponatremia on the Outcomes of Wait-Listed and Transplanted Patients With Liver Cirrhosis
Mohammed Eyad Yaseen Alsabbagh, MD, Bayan Alsuleiman,
MD, Naim Alkhouri, MD, Cleveland Clinic, Cleveland, OH
Between the Lines:
The Refractory Esophageal Patient – What the
Guidelines Do Not Address
MODERATOR: Evan S. Dellon, MD, MPH
10:00 am – 10:30 am SPECIAL LECTURE (Terrace Ballroom 3)
Achalasia: New Treatment Paradigms
Steven R. DeMeester, MD, FACG
Describe new treatments, including POEM, as well as patient selection for
surgical therapy and management of post-surgical complications.
The J. Edward Berk Distinguished Lecture –
GI and Endoscopic Training for the Future Gastroenterologist
Richard A. Kozarek, MD, FACG
Identify the fundamentals of GI and endoscopic training for
tomorrow’s GI. (See page 15 for more information.)
Introduced by: Harry E. Sarles, Jr., MD, FACG, ACG President
10:00 am – 4:30 pm
EXHIBIT HALL OPENS
(Exhibit Halls DE)
10:00 am – 4:30 pm
HANDS-ON WORKSHOP CENTER
(Exhibit Halls DE, Booth #104)
EoE: When Steroids Fail
Evan S. Dellon, MD, MPH
Discuss the reasons and treatment approaches for steroid-refractory EoE
patients, including dietary elimination and dilation.
Refractory GERD: What Are the Options in 2014?
Ronnie Fass, MD, FACG
Describe current treatment options for PPI-refractory GERD, optimal
selection of patients for surgery and post-op complications/recurrences.
10:30 am – 11:30 am BREAK – VISIT EXHIBITS
(Exhibit Halls DE)
12:45 pm – 2:15 pm LUNCH BREAK
(Exhibit Halls DE)
10:30 am – 11:30 am EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
12:45 pm – 2:15 pm POSTER SESSION
(Exhibit Halls DE)
11:30 am – 12:45 pm SIMULTANEOUS SYMPOSIA 3
12:45 pm – 1:15 pm EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
simultaneous symposia 3a:Quality
1:45 pm – 2:15 pm EXHIBITOR THEATER
(Exhibit Halls DE, Booth #1049)
2:15 pm – 3:45 pm SIMULTANEOUS PLENARY SESSIONS
Here and Now
in Colonoscopy: MODERATOR: Douglas K. Rex, MD, MACG
Quality Indicators in Colonoscopy and How to Improve Them in
Practice
Aasma Shaukat, MD, MPH, FACG
Define current quality indicators and discuss technology and techniques
to improve them in practice.
Plenary Session 1: Esophagus
MODERATORS: Nicholas J. Shaheen, MD, MPH, FACG
Marcelo F. Vela, MD, FACG
37. Efficacy of Topical Corticosteroids in the Treatment of
Eosinophilic Esophagitis: A Meta-Analysis and Systematic
Review of Placebo Controlled Randomized Clinical Trials
Ashutosh Gupta, MD, Venkatesh Ravi, MD, Arvind R. Murali,
MD, Bashar M. Attar, MD, PhD, FACG, Pramoda Koduru, MD,
John H. Stroger Hospital of Cook County, Chicago, IL
Detection and Resection of Serrated Polyps
Douglas K. Rex, MD, MACG
Determine the classification, pathology variation and methods to improve
detection and resection of serrated polyps.
Controversies in Surveillance Guidelines
Dennis J. Ahnen, MD
Analyze surveillance guidelines for serrated polyps and other grey areas.
38. Site Volume Is Inversely Associated With Recurrence Rate
After Successful Radiofrequency Ablation (RFA): An Analysis
of the U.S. RFA Registry
Cary C. Cotton, BA, W. Asher Wolf, MD, MPH, Srinadh Komanduri, MD, MS, Charles J. Lightdale, MD, MACG, Anthony
Infantolino, MD, FACG, Herbert C. Wolfsen, MD, FACG,
Nicholas J. Shaheen, MD, MPH, FACG, University of North
Carolina, Center for Esophageal Diseases and Swallowing,
Division of Gastroenterology and Hepatology, Chapel Hill, NC,
Northwestern University Feinberg School of Medicine, Chicago,
IL, Columbia University Department of Medicine, New York,
NY, Jefferson Medical College, Philadelphia, PA, Mayo Clinic
Florida, Jacksonville, FL
60
Annual Scientific Meeting Agenda – Tuesday, October 21
LATE-BREAKING ABSTRACTS
39. DNA Methylation Changes in Barrett’s Epithelium and Adjacent Normal Mucosa
Tamas A. Gonda, MD, Samuel Stevens, BA, Clare LaFave,
PhD, Charles J. Lightdale, MD, MACG, Benjamin Tycko, MD,
PhD, Gastroenterology, Columbia University Medical Center,
New York, NY
MODERATOR: Brian E. Lacy, MD, PhD, FACG
Late-Breaking Abstract
43. Comparative GI Safety of Dabigatran, Rivaroxaban and
Warfarin: Age-Related Differences Exist
Neena S. Abraham MD, MSCE, FACG, Herbert Heien MSc,
Lindsey R. Haas MPH, Nilay D. Shah PhD, Division of Gastroenterology, Department of Medicine, Mayo Clinic, Scottsdale,
Arizona; Division of Health Care Policy and Research, Department of Health Services Research, Mayo Clinic, Rochester,
MN; Mayo Clinic, Robert D. and Patricia E. Kern Center for
the Science of Health Care Delivery, Rochester, MN; Optum
Labs, Cambridge, MA
40. Endoscopic Radiofrequency Energy Delivery to the Lower
Esophageal Sphincter for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
2014 ACG Fellow Award
Seth Lipka, MD, Ambuj Kumar, MD, MPH, Joel E. Richter,
MD, MACG, Digestive Diseases and Nutrition, University of
South Florida, Morsani College of Medicine, Tampa, FL, Division of Evidence Based Medicine and Outcomes Research,
University of South Florida, Morsani College of Medicine,
Tampa, FL, Department of Digestive Diseases and Nutrition,
University of South FL, Morsani College of Medicine, Joy McCann Culverhouse Center for Swallowing Disorders, Tampa, FL
Late-Breaking Abstract
44. A Phase II, Placebo-Controlled Trial of Efficacy, Safety
and Pharmacodynamics of Relamorelin in Chronic Constipation
Andres Acosta, MD, PhD, Michael Camilleri, MD, FACG,
Gururaj Kolar, MD, Johanna Iturrino, MD, Lawrence Szarka,
MD, Amy Boldingh, Duane Burton, BS, Michael Ryks, Deborah Rhoten, Alan R. Zinsmeister, PhD, Sharon C. Spence,
Keith Gottesdiener, MD, Maria I. Vazquez-Roque, MD, MS,
Mayo Clinic, Rochester, MN, Mayo Clinic, Jacksonville, FL,
Rhythm Pharmaceuticals, Boston, MA
ANNUAL
MEETING
41. Transoral Fundoplication Provides Better GERD Symptom
Control Than PPIs in Patients With Troublesome Regurgitation:
A Multicenter Sham-Controlled Randomized Clinical Trial
Peter J. Kahrilas, MD, FACG, John Hunter, MD, Reginald Bell,
MD, Erik Wilson, MD, Karim Trad, MD, James Dolan, MD,
Kyle Perry, MD, Brant Oelschlager, MD, Nathaniel Soper, MD,
Miguel Burch, MD, W. Scott Melvin, MD, Kevin Reavis, MD,
Daniel Turgeon, MD, Eric Hungness, MD, Brian Diggs, PhD,
Brad Snyder, MD, Medicine, Northwestern University, Chicago,
IL, Oregon Health & Science University, Portland, OR, SurgOne Foregut Institute, Englewood, CO, University of Texas
Health & Science Center, Houston, TX, The George Washington University of Medicine and Health Sciences, Washington,
DC, Reston Surgical Associates, Reston, VA, The Ohio State
University, Columbus, OH, University of Washington, Seattle,
WA, Cedars-Sinai Medical Center, Los Angeles, CA, Oregon
Clinic, Portland, OR
Late-Breaking Abstract
45. Efficacy and Safety of Repeat Treatment With Rifaximin
for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D):
Results of the TARGET 3 Study
Anthony Lembo, MD, FACG, Mark Pimentel, MD, FACG,
Satish S. C. Rao, MD, FACG, Philip Schoenfeld, MD, FACG,
Brooks Cash, MD, FACG, Leonard B. Weinstock, MD, FACG,
Pamela L. Golden, PhD, Craig Paterson, MD, Enoch Bortey,
PhD, and William P. Forbes, PharmD, Beth Israel Deaconess
Medical Center, Boston, MA, Cedars-Sinai Medical Center, Los
Angeles, CA, Georgia Regents University, Augusta, GA, University of Michigan, Ann Arbor, MI, University of South Alabama,
Mobile, AL, Washington University School of Medicine, Hospital, St. Louis, MO, Salix Pharmaceuticals, Inc., Raleigh, NC
42. Improvement in Symptoms and QOL Is Sustained With Minimal Side Effects 4 Years After Magnetic Sphincter
Augmentation (LINX) for GERD
Philip O. Katz, MD, FACG, Kenneth R. DeVault, MD, FACG,
Steven A. Edmundowicz, MD, Steven C. Schlack-Haerer, MD,
Robert A. Ganz, MD, Einstein Medical Center, Philadelphia,
PA, Mayo Clinic Florida, Jacksonville, FL, Washington University School of Medicine, St. Louis, MO, Gundersen Health
System, La Crosse, Wisconsin, Minnesota Gastroenterology,
Minneapolis, MN
Plenary Session 2: Pancreatic / Biliary
MODERATORS: Linda S. Lee, MD
Scott M. Tenner, MD, MPH, JD, FACG
46. Rapid Point-of-Care Measurement of Cyst Fluid Glucose
Is Feasible and Accurate in Predicting Mucinous Pancreatic
Cysts
Thomas Zikos, MD, Kimberly Pham, MS, Ann Chen, MD,
Subhas Banerjee, MD, Shai Friedland, MD, MS, Monica Dua,
MD, Jeffrey Norton, MD, George Poultsides, MD, MS, Brenda
Visser, MD, Walter Park, MD, MS, Medicine/Gastroenterology,
Stanford University, Stanford, CA
47. RNA Sequencing of Cystic Lesions of the Pancreas
Sarah Rodriguez, MD, Terry Morgan, PhD, Brintha K. Enestvedt, MD, Carl Pelz, Gene Bakis, MD, Soren Impey, PhD, Gastroenterology, The Oregon Clinic-West, Portland, OR, Oregon
Health and Science University, Portland, OR
61
Annual Scientific Meeting Agenda – Tuesday, October 21
48. Risk Factors for Malignant Progression of Intraductal Papillary Mucinous Neoplasms (IPMN): An International Registry
Cohort
Maria Moris Felgueroso, MD, Michael B. Wallace, MD, FACG,
Massimo Raimondo, MD, FACG, Timothy A. Woodward, MD,
Verna J. Skinner, MD, Paolo G. Arcidiacono, MD, Cinzia
Boemo, MD, Maria C. Petrone, MD, Claudio De Angelis, MD,
Selene F. Manfre, MD, Pietro Fusaroli, MD, Michele Lewis,
MD, Mayo Clinic Jacksonville, Jacksonville, FL, San Raffaele
Scientific Institute, Milan, Italy, University of Turin, Turin,
Italy, Ospedale di Castel San Pietro Terme, Bologna, Italy
5:00 pm – 6:15 pm simultaneous symposia 4a:Obesity:
The Hunger Games
MODERATOR: Steven A. Edmundowicz, MD
Which Surgery Will Keep Your BMI in Check?
Alfons Pomp, MD
Compare the different surgical options in the management of obesity.
Post-operative Complications: Metabolic and Nutritional
John K. DiBaise, MD, FACG
Identify and manage the potential metabolic complications post-bariatric
surgery.
49. Morbid Obesity (MO) Is Associated With Increased Healthcare Utilization and Is an Independent Predictor of Mortality
of Acute Pancreatitis (AP)
Somashekar G. Krishna, MD, MPH, Samer El-Dika, MD, Alice
Hinton, PhD, Jeffrey R. Groce, MD, Hisham Hussan, MD,
Cheng Zhang, MD, PhD, Peter P. Stanich, MD, Na Li, MD,
Darwin L. Conwell, MD, MS, Department of Gastroenterology,
Hepatology and Nutrition, The Ohio State University Medical
Center, Columbus, OH
Post-operative Complications: Endoscopic Management
Steven A. Edmundowicz, MD
Define how to endoscopically manage post-bariatric surgical
complications.
simultaneous symposia 4b:Pearls
and Pitfalls of Routine
IBD Management: Case Studies
50. Acute Pancreatitis (AP) in Post-Bariatric Surgery (BRS)
Status: Analysis of National Trends, Complications and
Outcomes from 2007 to 2011
2014 ACG Obesity Award
Somashekar G. Krishna, MD, MPH, Jennifer Behzadi, MD,
Alice Hinton, PhD, Samer El-Dika, MD, Jeffrey R. Groce, MD,
Hisham Hussan, MD, Darwin L. Conwell, MD, MS, Department
of Gastroenterology, Hepatology and Nutrition, The Ohio State
University Medical Center, Columbus, OH
MODERATOR: Uma Mahadevan, MD, FACG
The Newly Diagnosed IBD Patient
Edward V. Loftus, Jr., MD, FACG
Apply appropriate initial therapy for newly diagnosed IBD patients.
The Medically Refractory IBD Patient
Uma Mahadevan, MD, FACG
Apply a comprehensive approach to the patient with refractory
symptoms.
51. Prevalence of Exocrine and Endocrine Pancreatic
Insufficiency After Sentinel Acute Pancreatitis (AP)
Kishore Vipperla, MD, Georgios Papachristou, MD, Adam
Slivka, MD, PhD, David Whitcomb, MD, PhD, Dhiraj Yadav,
MD, MPH, University of Pittsburgh Medical Center, Pittsburgh, PA
3:45 pm – 4:30 pm SIMULTANEOUS SYMPOSIA 4
The Post-operative Patient
Miguel D. Regueiro, MD, FACG
Apply a therapy for the prevention of recurrence.
6:15 pm BREAK – VISIT EXHIBITS
(Exhibit Halls DE)
4:30 pm – 5:00 pm SPECIAL LECTURE (Terrace Ballroom 3)
The Emily Couric Memorial Lecture – Cancer in IBD:
The Colon and Beyond
Stephen B. Hanauer, MD, FACG
Describe the role of surveillance techniques to prevent colon cancer
in IBD, and identify the risks of medication-related malignancies in IBD.
(See page 15 for more information.)
Introduced by: Harry E. Sarles, Jr., MD, FACG, ACG President
Sponsored by the ACG, the Virginia Gastroenterological Society, and
the Old Dominion Society of Gastroenterology Nurses and Associates
62
ADJOURN
Annual Scientific Meeting Agenda – Wednesday, October 22
Wednesday, October 22, 2014
breakfast p: Beyond
the Burn: Controversies in
Barrett’s Esophagus
6:45 am – 12:15 pm
6:00 am – 12:15 pm
MODERATOR: Nicholas J. Shaheen, MD, MPH, FACG
REGISTRATION (Broad Street Atrium)
Difficult Ablation: When to Step on the Pedal and When to
Refer
Kenneth K. Wang, MD, FACG
Discuss cases that present difficulty for ablation such as
nodularity, long segment BE, large hiatal hernias and esophageal
varices, and determine when they can be safely performed and
when a referral is needed.
6:45 am – 8:15 am
OPTIONAL BREAKFAST SESSIONS
Cost is $60 per person/per session. Separate registration
required. A USB containing all ACG 2014 Breakfast Sessions
submissions will be provided to attendees registered for any
Breakfast Session. See ticket for room assignment. If you have
not registered, vist the ACG Registration Desk.
breakfast n: Common
Afterburn: Surveillance After Ablation and Management of
Recurrence
Nicholas J. Shaheen, MD, MPH, FACG
Explain post-ablation surveillance protocols and the strategy for treating
BE recurrence after ablation.
Liver Outpatient Consults
MODERATOR: Santiago J. Munoz, MD, FACG
The Patient With a Solid Liver Mass
K. Rajender Reddy, MD, FACG
Distinguish between benign and malignant liver masses on imaging, and
develop strategies to screen for hepatoma in patients with advanced
fibrosis.
Esophagectomy in 2014: What Is the Role?
Steven R. DeMeester, MD, FACG
Describe the circumstance in which esophagectomy for BE is still
indicated, and differences between the U.S. and British guidelines.
The Abnormal Liver Panel
Santiago J. Munoz, MD, FACG
Evaluate abnormal liver tests and identify the presence or absence of
advanced liver disease.
breakfast q: Thinking
MODERATOR: Jason M. Swoger, MD, MPH
The Hepatitis B Infected Patient
Joseph K. Lim, MD, FACG
Interpret hepatitis B serologies to determine whether to follow or treat the
infected patient.
breakfast o: Practical
Skin
Jason M. Swoger, MD, MPH
Identify common skin manifestations of IBD and complications from
therapy.
Colonoscopy
Arthralgias
Christina Y. Ha, MD
Differentiate the causes and identify treatment of joint pain in the patient
with IBD.
MODERATOR: Joseph C. Anderson, MD
What’s New in Colonoscopy Prep
Brooks D. Cash, MD, FACG
Discuss recent data regarding various prep regimens, qualities,
and adjunctive measures to achieve an optimal bowel prep.
Abnormal Liver Function Tests
Paul Martin, MD, FACG
Outline common liver complications of IBD and IBD therapy.
The Incomplete Colonoscopy: What Next?
Jonathan A. Leighton, MD, FACG
Explain the options for patients who have an incomplete colonoscopy.
6:00 am – 12:15 pm REGISTRATION (Broad Street Atrium)
8:30 am – 12:15 pm
Approach to the Difficult Polypectomy
Charles J. Kahi, MD, FACG
Identify techniques for successful and complete polyp resection.
SCIENTIFIC MEETING
8:30 am – 10:15 am SIMULTANEOUS PLENARY SESSIONS
63
ANNUAL
MEETING
Outside the Bowel: Common
Complications of IBD and IBD Therapy
Annual Scientific Meeting Agenda – Wednesday, October 22
8:30 am – 10:15 am SIMULTANEOUS PLENARY SESSIONS
61. Association of Mean Vitamin D Level With Clinical Status
in Inflammatory Bowel Disease: A 5 Year Prospective Study
2014 ACG Fellow Award
Toufic A. Kabbani, MD, MPH, Claudia Ramos Rivers, MD, Jason Swoger, MD, MPH, Miguel D. Regueiro, MD, FACG, Arthur
M. Barrie, MD, PhD, Marc Schwartz, MD, Jana G. Hashash,
MD, Leonard Baidoo, MD, FACG, Michael A. Dunn, MD, David
G. Binion, MD, University of Pittsburgh Medical Center, Pittsburgh, PA
Plenary Session 1: IBD / Small Intestine / Unclassified
MODERATORS: Francis A. Farraye, MD, MSc, FACG
Jonathan A. Leighton MD, FACG
55. The Clinical Characteristics of HLA Genotype DQ2.2 in a
U.S. Adult Celiac Disease Population
2014 ACG Fellow Award
Richard Wu, MD, MPH, Stephanie Moleski, MD, C. Andrew
Kistler, MD, PharmD, Beth Colombe, PhD, Anthony DiMarino,
MD, Thomas Jefferson University Hospital, Philadelphia, PA
62. Health Outcomes of Ulcerative Colitis (UC) and Crohn’s Disease (CD) Patients Hospitalized With Human Cytomegalovirus (CMV) Disease
Cheng Zhang, MD, Edward J. Levine, MD, Somashekar G.
Krishna, MD, Alice Hinton, PhD, Darwin L. Conwell, MD,
Razvan Arsenescu, MD, Inflammatory Bowel Disease Program,
Division of Gastroenterology, Hepatology, & Nutrition, The Ohio
State University, Columbus, OH; Division of Biostatics, College
of Public Health, The Ohio State University, Columbus, OH
56. Impact of Small Bowel Imaging on the Histological Patterns of Small Bowel Tumors: Analysis With SEER Database
2014 ACG Lawlor Resident Award
Felix H. Lui, MD, Richard E. Shaw, PhD, Lauren B. Gerson,
MD, FACG, Internal Medicine, California Pacific Medical
Center, San Francisco, CA; Division of Clinical Informatics,
California Pacific Medical Center, San Francisco, CA; Division
of Gastroenterology, California Pacific Medical Center, San
Francisco, CA
63. The Risk of a Second Non-Melanoma Skin Cancer With
Thiopurine and Anti-TNF Use in Inflammatory Bowel Disease
Frank I. Scott, MD, MSCE, Ronac Mamtani, MD, MSCE, Colleen Brensinger, MS, Kevin Haynes, PharmD, MSCE, Zelma C.
Chiesa-Fuxench, MD, Jie Zhang, PhD, Lang Chen, MD, PhD,
Fenglong Xie, MS, David J. Margolis, MD, PhD, Jeffrey R.
Curtis, MD, MS, MPH, James D. Lewis, MD, MSCE, Abramson
Cancer Center, Perelman School of Medicine, University of
Pennsylvania, Philadelphia, PA, Department of Epidemiology,
University of Alabama at Birmingham School of Public Health,
Birmingham, AL, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham,
AL, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Division of
Gastroenterology, Perelman School of Medicine, University of
Pennsylvania, Philadelphia, PA, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University
of Pennsylvania, Philadelph, PA
57. Small Bowel Cancer in the U.K.
Lolita Chan, BSc, MBChB, MCRP, Gareth Evans, MBBS,
MRCP, MD, FRCP, Central Manchester University Hospitals
NHS Foundation Trust, Manchester, United Kingdom
58. Mode of Childbirth and Long-term Outcomes in Women
With Inflammatory Bowel Diseases
2014 ACG Governors Award for Excellence in Clinical Research
Ashwin N. Ananthakrishnan, MD, MPH, Andrew Cagan, BS,
Vivian Gainer, MS, Tianxi Cai, PhD, Stanley Shaw, MD, PhD,
Susanne Churchill, PhD, Elizabeth Karlsin, MD, MPH, Shawn
Murphy, MD, PhD, Isaac Kohane, MD, PhD, Katherine Liao,
MD, MPH, Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA; Harvard School of Public Health, Boston,
MA, Brigham and Women’s Hospital, Boston, MA, Partners
Healthcare, Boston, MA
Plenary Session 2: Stomach / Colon
59. Updated Incidence and Prevalence of Crohn’s Disease
and Ulcerative Colitis in Olmsted County, Minnesota (between
1970 and 2010)
2014 ACG IBD Research Award
Raina Shivashankar, MD, William J. Tremaine, MD, FACG,
Scott W. Harmsen, MS, Alan Zinsmeister, PhD, Edward V. Loftus, MD, FACG, Gastroenterology and Hepatology, Mayo Clinic,
Rochester, MN
MODERATORS: Joseph C. Anderson, MD
Francisco C. Ramirez, MD, FACG
64. Risks of Thromboembolism Versus Recurrent GI
Hemorrhage After Interruption of Anticoagulation in Admitted
Patients With GI Bleeding (GIB) – A Prospective Study
Neil Sengupta, MD, Joseph Feuerstein, MD, Vilas R.
Patwardhan, MD, Gyanprakash Ketwaroo, MD, Adarsh M.
Thaker, MD, Daniel Leffler, MD, Beth Israel Deaconess
Medical Center, Boston, MA
60. Impact of Immigration on Phenotype and Severity of
Inflammatory Bowel Disease: A Prospective Cohort Study of
Hispanics in the United States
2014 ACG IBD Research Award
Nirupama Bonthala, MD, Jared Macklin, MD, Syeda Hamadani, MD, Mark Salem, MD, Rachel Demisse, MD, Beverly Chen,
MD, Caroline Hwang, MD, Gastroenterolgy and Hepatology,
University of Southern California, Los Angeles, CA
65. Topographical Mapping in a Cohort of Patients With Gastric Intestinal Metaplasia
2014 ACG Fellow Award
Manish B. Singla, MD, Steven Armbruster, MD, Nisha Shah,
MD, Molly Burman, BSN, Corinne L. Maydonovitch, BS, Patrick E. Young, MD, FACG, Jayde Kurland, MD, FACG, Scott
Itzkowitz, DO, FACG, Walter Reed National Military Medical
Center, Washington, DC, Gastrointestinal Associates, Lima, OH
64
Annual Scientific Meeting Agenda – Wednesday, October 22
66. An Assessment of Gastric and Small Bowel Pressure
Profiles in Diabetics With Gastroparesis Before and During 28
Days of Treatment With the Motilin Receptor Agonist Camicinal (GSK962040)
Kenneth Barshop, MD, George Dukes, MD, Matthew Barton,
MD, Jack Semler, MD, Braden Kuo, MD, University of Chicago
Pritzker School of Medicine, Chicago, IL, Massachusetts General Hospital, Boston, MA, GlaxoSmithKline, Raleigh, NC
10:15 am – 10:45 am SPECIAL LECTURE (Terrace Ballroom 3)
The David Y. Graham Lecture – Idiosyncratic Drug-Induced
Liver Injury: What Have We Learned in the Last Decade?
Naga P. Chalasani, MD, FACG
Assess recent developments in the diagnosis and management of
DILI. (See page 15 for more information.)
Introduced by: Harry E. Sarles, Jr., MD, FACG, ACG President
67. Gastric Electric Stimulation: A Prospective Analysis of
151 Patients at a Single Center
Jason Heckert, BS, Sean Harbison, MD, Henry P. Parkman,
MD, FACG, Temple University, Philadelphia, PA
10:45 am – 11:00 am BREAK
68. Colorectal Cancer Patients Have Higher Rates of Advanced Features in Their Diminutive Adenomas Compared to
Patients Undergoing Average-Risk Screening
2014 ACG Colorectal Cancer Prevention Award
Amoah Yeboah-Korang, MD, MPH, MSc, Philip Vutien, MD,
Kateri Evans, MS, Michael Greenspan, MD, Sohrab Mobarhan,
MD, Shriram Jakate, MD, Joshua Melson, MD, MPH, Rush
University Medical Center, Chicago, IL
simultaneous symposia 5a:The
11:00 am – 12:15 pm SIMULTANEOUS SYMPOSIA 5
Inpatient Hepatology
Consult
MODERATOR: Mark W. Russo, MD, MPH, FACG
Fluid, Distention, Infection, Oh My: Approach to the Patient
With Ascites
Mark W. Russo, MD, MPH, FACG
Treat patients with massive ascites and spontaneous bacterial
peritonitis.
Water, Water Everywhere: Approach to the Cirrhotic Patient With
Acute Kidney Injury
Jasmohan S. Bajaj, MD, FACG
Evaluate the cirrhotic patient with acute kidney injury, including
hepatorenal syndrome, acute kidney injury and hyponatremia.
A Rational Guide to the Use of TIPS
Atif Zaman, MD, MPH, FACG
Discuss appropriate indications for TIPS referrals and manage post-TIPS
complications.
70. Comparing Diagnostic Tests in Dyssynergic DefecationConstipation
Danse Bi, MD, Sandra Sostrich, MD, Mojtaba Olyaee, MD,
Elena Sidorenko, MD, Tuba Esfandyari, MD, University of Kansas Medical Center, Kansas City, KS
simultaneous symposia 5b:The
Human Microbiome
MODERATOR: Eamonn M. M. Quigley, MD, FACG
71. Clostridium difficile Associated Risk of Death Score
(CARDS): A Novel Risk Score to Predict Mortality Among Hospitalized Patients With Clostridium difficile Infection
2014 ACG Fellow Award
Zain Kassam, MD, MPH, Camila Cribb Fabersunne, MD, MPH
Candidate, Mark B. Smith, MD, PhD Candidate, Gilaad G.
Kaplan, MD, MPH, Geoffrey C. Nguyen, MD, PhD, Ashwin N.
Ananthakrishnan, MBBS, MPH, Massachusetts Institute of
Technology, Cambridge, MA, Harvard Medical School, Boston,
MA, University of Calgary, Calgary, Alberta, Canada, University
of Toronto, Toronto, Ontario, Canada, Massachusetts General
Hospital, Boston, MA
Human Intestinal Microbiome: What the Practicing
Gastroenterologist Should Know
Eamonn M. M. Quigley, MD, FACG
Identify how the microbiome functions and interacts within the
GI tract.
What Is the Evidence that the Intestinal Microbiome Has a Role in
Gastrointestinal Diseases?
Lawrence J. Brandt, MD, MACG
Define the role of the human microbiome in relation to GI disorders.
Targeting the Intestine Microbiota in the Treatment of
Gastrointestinal Diseases
Yehuda Ringel, MD, FACG
Assess the role of the human microbiome in the treatment of GI diseases.
72. Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation (FMT) for Multiple Recurrent C. difficile Infection (CDI)
Zhi-Dong Jiang, PhD, Nadim J. Ajami, PhD, Todd Lasco, PhD,
Joe Petrosino, PhD, Fredric Hochman, MD, Victor AnkomaSey, MD, Matthew Wong, PhD, Ashley Alexander, MS, Shi Ke,
MS, Herbert L. DuPont, MD, University of Texas SPH, Houston, TX, Baylor College of Medicine, Houston, TX, Baylor St.
Luke’s Medical Center, Houston, TX
12:15 pm
65
ANNUAL SCIENTIFIC MEETING ADJOURNS
ANNUAL
MEETING
69. Insertion Water Exchange Minimizes Endoscopist
Multitasking During Withdrawal Inspection: A Plausible
Explanation for Enhanced Polyp Detection in the Right Colon
Andrew Yen, MD, FACG, Victoria Y. Yung, MD, Joseph W.
Leung, MD, MACG, Surinder Mann, MD, FACG, Machelle
D. Wilson, PhD, Felix W. Leung, MD, FACG, Sacramento
VA Medical Center, VANCHCS, Mather, CA, University of
California, Davis Medical Center, Sacramento, CA, Sepulveda
Ambulatory Care Center, VAGLAHS, North Hills, CA

Download Report